 Toward a Sustainable Cord Blood Supply in the United StatesSave the Cord Foundation and WellSky are proud to welcome Kandice Kapinos, Ph.D. of the RAND Corporation for our next edition of Share the Science on Wednesday, February 27th, 2019. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here. In 2005, the US government recognized the need for a federal cord blood donation program. This moment marked a major advancement in stem cell therapies as the government sought to fulfill a need and better standardize the cord blood banking requirements. At the time, the government recognized a need for a centralized public stem cell registry which could provide an ethnically diverse and high-quality source of stem cells easily accessible for patients in need. This was the beginning of the National Cord Blood Inventory (NCBI), operated by the National Marrow Donor Program / Be The Match. As we know, cord blood has been used for many years to treat patients suffering from life-threatening diseases including leukemia, lymphoma and sickle cell anemia. In fact, donated cord blood is recognized as a possible treatment for over 80 different diseases. Cord blood also holds great promise in the field of regenerative medicine for autism, spinal cord injury, hearing loss and more.
SHARE THE SCIENCE with Kandice Kapinos, PhD Economist for the RAND Corporation "Towards a Sustainable Cord Blood Supply for the United States" Free webinar. Open to the public Wednesday, February 27th, 2019 at 11am Central Time About the Speaker Kandice Kapinos is a health and labor economist at the RAND Corporation. Her research broadly focuses on health economics, health services research and the economics of prevention, particularly for vulnerable populations. She is currently leading a study on access to care in California Workers’ Compensation system and contributing to two studies on telehealth and one on disability among the self-employed. Recently she has completed several child and maternal health studies, including studies of peer and environmental effects in adolescent obesity and pregnancy; effects of perinatal maternal weight trajectories on maternal and child health outcomes, the effects of Cesarean deliveries on maternal health, and the cord blood industry. She also has extensive experience with health care reform and health policy evaluation studies across a wide range of health topics. Much of this work has been focused in the area of policies aimed at improving preventive health utilization She has advanced applied econometric and survey methodological skills. She previously worked at the University of Michigan, the US Census Bureau and Abt Associates. She completed a post-doctoral fellowship at the Center for Chronic Disease Outcomes Research at the Minneapolis VA Medical Center, a VA Health Services Research and Development (HSR&D) Center of Excellence. Kapinos received her Ph.D. in labor economics/human resources from the University of Illinois at Urbana-Champaign. We wish to thank Kandice Kapinos for volunteering her time to speak on Share the Science and sharing her valuable insight on the cord blood industry. We also wish to thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series.
Odds are that you know someone who has been diagnosed as autistic or suspects such a diagnosis. The person may be a child, adolescent or adult. In 2016, the Center for Disease Control - Autism and Developmental Disabilities Monitoring (ADDM) Network estimated that autism was diagnosed in 1 of every 68 births. In fact, in that same report, they also warned that this number has been on the rise. For those with severe autism, medicine has not provided many answers. But, this could be changing thanks to cord blood stem cells. . .
UPDATE: Following this special edition of Share the Science with Dr. Michael Chez, he offered to answered additional questions sent to us based on his presentation. Please find these questions and his detailed responses below. We wish to thank Dr. Chez for generously sharing his expertise and taking the time to answer these additional questions.
Read the full list of questions and responses below. Autism: Are we on the verge of a revolution in medicine?
Save the Cord Foundation and WellSky are proud to welcome Michael G. Chez, M.D. for our next edition of Share the Science on December 12th, 2018. Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field. As always, we invite both health professionals and the general public to join us for this unique online educational series.
During his presentation for Share the Science, Dr. Chez present a broad overview of past and current clinical trials applying stem cell therapy to autism spectrum disorders, as well as future therapeutic opportunities. He will explain the theories behind why stem cell therapy may be useful in autism treatment options. He will discuss recent trials using autologous umbilical cord and other stem cell sourced treatments, as well as the results of those trials. He will also look a the risks and safety of, and the limitations found to date in applying, stem cell therapy.
REGISTER now to join us for this one-to-one chat with Dr. Chez. Ask your questions directly to him and get the information you need.
SHARE THE SCIENCE
with Dr. Michael Chez "Stem Cell Therapy in Autism: Experience and Outcomes" Wednesday, December 12, 2018 | 11:00 AM CS
Free online event. Open to the public. Registration required.
RECORDING NOW AVAILABLE
Dr. Michael Chez Answers Your Questions
Post-conference Question / Answer Session
About the Speaker
Dr. Chez is a board-certified child neurologist and fellowship-trained pediatric epileptologist who has pioneered research in epilepsy treatment and epilepsy surgery monitoring, and the use of alternative therapies to treat autism.
Dr. Chez received his medical degree from the Indiana University School of Medicine and served his internship and residency in pediatrics at Johns Hopkins Hospital. He was awarded a fellowship in child neurology at Children's Memorial Hospital in Chicago, a fellowship at the Cleveland Clinic Foundation in Cleveland, and a fellowship in epilepsy at Rush Presbyterian-St. Luke's Medical Center. Dr. Chez has been certified by the American Board of Pediatrics, and the American Board of Psychiatry and Neurology, with special competence in child neurology.
* * *
We wish to thank Dr. Michael Chez for volunteering his time to speak on Share the Science and sharing his valuable insight on cord blood stem cell therapies. We also wish to thank our generous sponsor and partner for this event, WellSky Health, who continue to support cord blood education through our “Share the Science” series.
 Research exploring the use of cord blood derived therapies is growing and Dr. Joanne Kurtzberg is one of the leading pioneers in this field. Learn about these therapies and the potential use of DUOC-1 as well as the encouraging results of Dr. Kurtzberg's research this October at #ShareTheScience LIVE during the AABB 2018 Annual Meeting. This free special session will be brought to you by Save the Cord Foundation thanks to the generous support of WellSky Health (formerly known as Mediware, Inc.). Have we crossed into new territory with cord blood? This year the world celebrates 30 years since the first cord blood transplant was performed. Dr. Joanne Kurtzberg was there. Indeed, Matthew Farrow was her patient. Working together with an international team led by Dr. Eliane Gluckman, the hope was that a cord blood transplant from Matthew's sister would cure him of fanconi anemia. The procedure worked. Thanks to this groundbreaking use of cord blood stem cells, Matthew grew up strong and healthy. Today, he is an adult with his own family. He is living proof that cord blood saves lives. Yet, this milestone procedure opened the door to a multitude of potential uses for cord blood. Today, cord blood is routinely used to treat more than 80 different life-threatening diseases including many blood cancers. We are also seeing exciting research in the use of cord blood stem cells for regenerative medicine. In particular, researchers are beginning to manipulate cord blood and develop cord blood derived therapies. Dr. Kurtzberg is one of the best known researchers in this field working primarily with children suffering from various brain injuries. Her studies in children with selective inborn errors of metabolism have shown that cord blood cells, administered intravenously after myeloablative therapy engraft in the brain. DUOC-01, a cord blood derived cellular therapy that promotes myelination, is undergoing testing to augment standard umbilical cord blood treatment in children with leukodystrophies. Dr. Kurtzberg explains that these observations have led us to hypothesize that cord blood cells might also have efficacy treating patients with acquired brain injuries. Clinical studies to date have been performed to demonstrate safety and efficacy of intravenous infusions of autologous cord blood in babies with hypoxic ischemic encephalopathy, young children with cerebral palsy, congenital hydrocephalus and autism, and adults with acute ischemic stroke. Further development of these therapies using allogeneic cord blood products can provide access to these therapies for all. On October 15th, we invite you to join us for a special session at the AABB 2018 Annual Meeting where we will host Dr. Kurtzberg for a live Share the Science event. At this event, she will speak about her current research and present the latest results from that work. She will highlight how cord blood banking and transplantation is continuing to evolve. She will also speak about the importance of quality for cord blood units and explain why, if not handled properly, poor quality standards could turn hope into disaster. Attendees will learn the latest in new clinical applications and have an opportunity to participate in a question/answer session with Dr. Kurtzberg. Extending Cord Blood to Regenerative Therapies for the Brain Boston Convention Center in room 151 AB | October 15th from 7:00 - 8:15 a.m. ET Event is RSVP only. Admission is free but seating is limited. About the speaker Dr. Joanne Kurtzberg is an internationally renowned expert in pediatric hematology/oncology, pediatric blood and marrow transplant, umbilical cord blood banking and transplant, and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine. Over the last two decades, Dr. Kurtzberg has established an internationally known pediatric transplant program; one of the largest unrelated donor cord blood banks, the Carolinas Cord Blood Bank, in the world; and the Julian Robertson Cell and Translational Therapy Program (CT2) at Duke. Dr. Kurtzberg has published more than 300 peer-reviewed papers, multiple chapters, and scientific reviews. She is a member of the American Society of Hematology, the American Association of Blood and Marrow Transplantation, the American Society of Pediatric Hematology/Oncology, the International Society of Cellular Therapies, the Pediatric Blood and Marrow Transplant Consortium (PBMTC), and other organizations. She serves on the Board of the Foundation of Accreditation of Cellular Therapies, Advisory Council of Blood Stem Cell Transplantation to Health and Human Services. Dr. Kurtzberg was awarded a Lifetime Achievement Award from the PBMTC in 2012. * * * We wish to thank Dr. Kurtzberg for volunteering her time to speak on Share the Science and sharing her valuable insight on cord blood derived therapies. We also wish to thank our generous sponsor and partner for this event, WellSky Health (formerly known as Mediware, Inc.), who continue to support cord blood education through our “Share the Science” series.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2019
Categories |
RSS Feed
